SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-023972
Filing Date
2018-10-04
Accepted
2018-10-04 16:15:22
Documents
6
Period of Report
2018-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prtk-8k_20181004.htm 8-K 51490
2 EX-10.1 prtk-ex101_6.htm EX-10.1 67182
3 EX-10.2 prtk-ex102_7.htm EX-10.2 20234
4 EX-99.1 prtk-ex991_8.htm EX-99.1 31617
5 GRAPHIC gcjaqofeytgh000001.jpg GRAPHIC 19383
6 GRAPHIC gglzd4zoexjs000001.jpg GRAPHIC 13217
  Complete submission text file 0001564590-18-023972.txt   217160
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 181108066
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1